FR24C1015I1 - Derives 2,2-difluoropropionamide de bardoxolone methyle, leurs formes polymorphes et leurs procedes d'utilisation - Google Patents

Derives 2,2-difluoropropionamide de bardoxolone methyle, leurs formes polymorphes et leurs procedes d'utilisation

Info

Publication number: FR24C1015I1
Authority: FR; France
Prior art keywords: methods; polymorphic forms; bardoxolone methyl; difluoropropionamide; derivatives
Prior art date: 2012-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR24C1015C

Other languages

English (en)

French (fr)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Reata Pharmaceuticals Holdings LLC

Original Assignee

Reata Pharmaceuticals Holdings LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-27

Filing date

2024-04-17

Publication date

2024-06-28

2024-04-17 Application filed by Reata Pharmaceuticals Holdings LLC filed Critical Reata Pharmaceuticals Holdings LLC

2024-06-28 Publication of FR24C1015I1 publication Critical patent/FR24C1015I1/fr

Status Active legal-status Critical Current

Links

WPTTVJLTNAWYAO-KPOXMGGZSA-N Bardoxolone methyl Chemical compound C([C@@]12C)=C(C#N)C(=O)C(C)(C)[C@@H]1CC[C@]1(C)C2=CC(=O)[C@@H]2[C@@H]3CC(C)(C)CC[C@]3(C(=O)OC)CC[C@]21C WPTTVJLTNAWYAO-KPOXMGGZSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

FR24C1015C 2012-04-27 2024-04-17 Derives 2,2-difluoropropionamide de bardoxolone methyle, leurs formes polymorphes et leurs procedes d'utilisation Active FR24C1015I1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201261687669P	2012-04-27	2012-04-27
US201361775288P	2013-03-08	2013-03-08
US201361780444P	2013-03-13	2013-03-13
PCT/US2013/038064 WO2013163344A1 (en)	2012-04-27	2013-04-24	2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

Publications (1)

Publication Number	Publication Date
FR24C1015I1 true FR24C1015I1 (fr)	2024-06-28

Family

ID=49483867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR24C1015C Active FR24C1015I1 (fr)	2012-04-27	2024-04-17	Derives 2,2-difluoropropionamide de bardoxolone methyle, leurs formes polymorphes et leurs procedes d'utilisation

Country Status (39)

Country	Link
US (4)	US8993640B2 (el)
EP (2)	EP3444261B1 (el)
JP (2)	JP6410710B2 (el)
KR (1)	KR102101774B1 (el)
CN (1)	CN104395332B (el)
AR (1)	AR092823A1 (el)
AU (1)	AU2013251602B2 (el)
BR (1)	BR112014026640B1 (el)
CA (1)	CA2869783C (el)
CL (1)	CL2014002886A1 (el)
CO (1)	CO7170182A2 (el)
CY (2)	CY1119333T1 (el)
DK (2)	DK3444261T3 (el)
DO (1)	DOP2014000236A (el)
EA (1)	EA030468B1 (el)
ES (2)	ES2861393T3 (el)
FI (1)	FIC20240012I1 (el)
FR (1)	FR24C1015I1 (el)
HK (2)	HK1207086A1 (el)
HR (1)	HRP20171275T1 (el)
HU (3)	HUE035673T2 (el)
IL (1)	IL235275B (el)
LT (2)	LT3444261T (el)
ME (1)	ME02926B (el)
MX (1)	MX357060B (el)
MY (1)	MY172750A (el)
NL (1)	NL301276I2 (el)
NZ (1)	NZ630222A (el)
PE (1)	PE20150160A1 (el)
PL (2)	PL2841445T3 (el)
PT (2)	PT3444261T (el)
RS (2)	RS61544B1 (el)
SG (1)	SG11201406868XA (el)
SI (2)	SI3444261T1 (el)
TW (2)	TWI623548B (el)
UA (1)	UA116209C2 (el)
UY (1)	UY34764A (el)
WO (1)	WO2013163344A1 (el)
ZA (1)	ZA201407326B (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2009203941B2 (en)	2008-01-11	2015-03-12	Reata Pharmaceuticals Holdings, LLC	Synthetic triterpenoids and methods of use in the treatment of disease
WO2009146218A2 (en)	2008-04-18	2009-12-03	Reata Pharmaceuticals, Inc.	Compounds including an anti-inflammatory pharmacore and methods of use
PT2276493T (pt)	2008-04-18	2019-01-10	Reata Pharmaceuticals Inc	Moduladores de inflamação anti-oxidantes: derivados de ácidos oleonucleicos com uma modificação no grupo aminno e outras modificações em c-17
SG191181A1 (en)	2010-12-17	2013-07-31	Reata Pharmaceuticals Inc	Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
US20130158077A1 (en)	2011-12-19	2013-06-20	Ares Trading S.A.	Pharmaceutical compositions
BR112014026640B1 (pt)	2012-04-27	2021-05-18	Reata Pharmaceuticals, Inc	compostos derivados de 2,2-difluoropropionamida de metil bardoxolona, formas polimórficas, composição farmacêutica, e uso dos mesmos
US9556222B2 (en)	2012-06-15	2017-01-31	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
CA2882418C (en)	2012-09-10	2021-05-04	Reata Pharmaceuticals, Inc.	C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY39092A (es) *	2013-04-24	2021-03-26	Abbvie Inc	Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
WO2016070063A1 (en)	2014-10-31	2016-05-06	The Regents Of The University Of California	Compositions and methods for treating hiv-associated cognitive dysfunction
KR102686868B1 (ko)	2015-02-12	2024-07-19	리아타 파마슈티컬즈, 아이엔씨.	항산화 염증 조절제로서의 이미다졸릴 트리사이클릭 에논
KR20180061251A (ko)	2015-09-23	2018-06-07	리아타 파마슈티컬즈, 아이엔씨.	Il-17의 저해를 위한 c4-변형된 올레아놀산 유도체 및 다른 용도
AU2017356955B2 (en)	2016-11-08	2023-11-09	Reata Pharmaceuticals Holdings, LLC	Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof
TWI831738B (zh)	2016-12-16	2024-02-11	美商瑞塔醫藥有限責任公司	用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
CN112384807A (zh) *	2018-05-24	2021-02-19	雷尼布斯治疗公司	治疗有风险患有肾损伤和肾衰竭的患者的方法
CA3103726A1 (en)	2018-06-15	2019-12-19	Reata Pharmaceuticals, Inc.	Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma
US12060340B2 (en)	2018-06-20	2024-08-13	Reata Pharmaceuticals, Inc	Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
IL280950B2 (en)	2018-08-20	2023-12-01	Janssen Pharmaceutica Nv	KEAP1-NRF2 protein-protein interaction inhibitors
US20220133748A1 (en) *	2019-02-15	2022-05-05	Triterpenoid Therapeutics, Inc.	Methods and compositions for inhibiting the nlrp3 inflammasome and/or lon protease
CN115023236A (zh) *	2019-12-03	2022-09-06	贝勒医学院	用于胰岛素抵抗的使用方法的治疗性化合物
EP4093377A1 (en)	2020-01-24	2022-11-30	Tvardi Therapeutics, Inc.	Therapeutic compounds, formulations, and uses thereof
WO2022126129A1 (en)	2020-12-11	2022-06-16	Reata Pharmaceuticals, Inc.	Synthetic triterpenoids for use in therapy
TW202245795A (zh) *	2021-01-18	2022-12-01	美商瑞塔醫藥有限責任公司	合成之熊果酸衍生物及其使用方法
CN113197905B (zh) *	2021-04-23	2022-04-19	浙江大学	三萜类化合物在制备神经母细胞瘤治疗药物中的应用
CN113358627B (zh) *	2021-06-23	2022-07-01	华中农业大学	一种基于拉曼检测的田间快速测定茶树品质成分的方法
CN114344308A (zh) *	2021-12-22	2022-04-15	山西医科大学第二医院	甲基巴多索隆在制备防治骨关节炎的药物中的应用
WO2023244946A1 (en)	2022-06-15	2023-12-21	Tvardi Therapeutics, Inc.	Prodrugs of stat3 inhibitors
EP4349847A1 (en)	2022-09-21	2024-04-10	Sicor Società Italiana Corticosteroidi S.r.l.	Process and intermediates for preparation of omaveloxolone and salts thereof

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5555153Y2 (el)	1975-03-19	1980-12-20
NZ191586A (en)	1978-10-10	1981-10-19	Sterling Drug Inc	Cyanoketones derived from glycyrrhetinic acid and pharmaceutical compositions
US4395423A (en)	1978-10-10	1983-07-26	Sterling Drug Inc.	Polycyclic cyanoketones
US5064823A (en)	1988-08-24	1991-11-12	Research Triangle Institute	Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
US6025395A (en)	1994-04-15	2000-02-15	Duke University	Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US6369101B1 (en)	1999-02-26	2002-04-09	Regents Of The University Of Minnesota	Therapeutic method to treat herpes virus infection
CN1361760A (zh)	1999-05-14	2002-07-31	尼瑞斯药品公司	新的白介素－1和肿瘤坏死因子－α调节剂、所述调节剂的合成以及使用所述调节剂的方法
US6649654B1 (en)	1999-11-23	2003-11-18	The Regents Of The University Of California	Methods for identifying and using IKK inhibitors
JP2001240573A (ja)	2000-03-01	2001-09-04	Meiji Seika Kaisha Ltd	トリテルペン誘導体及び肝疾患治療剤
WO2002003996A1 (en)	2000-07-12	2002-01-17	RAJKUMAR, Sujatha	Use of dammarane-type tritepenoid saporins
WO2002026762A1 (en)	2000-09-29	2002-04-04	Regents Of The University Of Minnesota	Triterpenes having antibacterial activity
EP1322661A1 (en)	2000-09-29	2003-07-02	Regents Of The University Of Minnesota	Triterpenes having fungicidal activity against yeast
US6951847B2 (en)	2000-09-29	2005-10-04	Regents Of The University Of Minnesota	Methods of treating fungal infections using lupeol
US6878751B1 (en)	2000-10-19	2005-04-12	Imperial College Of Science Technology And Medicine	Administration of resveratrol to treat inflammatory respiratory disorders
US7435755B2 (en)	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
EP1395255A4 (en)	2000-11-28	2007-09-12	Univ Texas	CDDO COMPOUNDS AND COMBINATION THERAPIES THEREOF
CN1636058B (zh)	2001-05-14	2011-06-08	龚大为	新型丙氨酸转氨酶及其应用方法
CA2472581C (en)	2002-01-15	2012-06-26	Trustees Of Dartmouth College	Tricyclic-bis-enone derivatives and methods of use thereof
DE60325329D1 (de)	2002-01-18	2009-01-29	Univ Minnesota	Quaternäre terpensalze als biologisch aktive tenside
US6974801B2 (en)	2002-05-13	2005-12-13	The Trustees Of Dartmounth College	Inhibitors and methods of use thereof
US20050014730A1 (en)	2003-04-02	2005-01-20	Carlson Robert M.	Anti-fungal formulation of triterpene and essential oil
WO2005042002A2 (en)	2003-10-30	2005-05-12	Entelos, Inc.	Treatment of rhematoid arthritis with flip antagonists
US8288439B2 (en)	2003-11-04	2012-10-16	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for the inhibition of HIV-1 replication
US20060258752A1 (en)	2004-02-12	2006-11-16	Vander Jagt David L	Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
JP2005314381A (ja)	2004-03-30	2005-11-10	Anges Mg Inc	増殖性腎疾患の予防・治療・改善剤
JP5087400B2 (ja)	2004-09-07	2012-12-05	パシフィックアローリミテッド	アンゲロイル基を有する抗腫瘍化合物
CA2614110A1 (en)	2005-07-01	2007-01-11	The Johns Hopkins University	Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
JP2009530405A (ja)	2006-03-23	2009-08-27	アドバンストライフサイエンシズインコーポレイテッド	合成五環性トリテルペノイド、ならびにベツリン酸およびベツリンの誘導体
US20070249561A1 (en)	2006-04-25	2007-10-25	Taylor Bradley K	Pharmacological method for treatment of neuropathic pain
CA2653726C (en)	2006-06-27	2015-05-12	Wellington Laboratories Inc.	Glycyrrhetinic acid derivatives
WO2008016095A1 (fr)	2006-08-02	2008-02-07	Santen Pharmaceutical Co., Ltd.	REMÈDE PRÉVENTIF OU CURATIF POUR LES KÉRATOCONJONCTIVITES CONTENANT UN ACTIVATEUR DE Nrf2 EN TANT QUE MATIÈRE ACTIVE
JP2008110962A (ja)	2006-08-02	2008-05-15	Santen Pharmaceut Co Ltd	Ｎｒｆ２活性化物質を有効成分として含む角結膜障害の予防または治療剤
JP2010510243A (ja)	2006-11-17	2010-04-02	トラスティーズオブダートマスカレッジ	三環系−ビス−エノン（ｔｂｅ）の合成および生物学的活性
US8299046B2 (en)	2006-11-17	2012-10-30	Trustees Of Dartmouth College	Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
PT2653873T (pt)	2007-02-08	2022-07-26	Biogen Ma Inc	Composições e utilizações para o tratamento de esclerose múltipla
JP2008247898A (ja)	2007-03-08	2008-10-16	Santen Pharmaceut Co Ltd	トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
US20080254055A1 (en)	2007-04-11	2008-10-16	John Erich Oblong	Compositions for Regulation of Hair Growth
WO2008136838A1 (en)	2007-05-04	2008-11-13	Trustees Of Dartmouth College	Novel amide derivatives of cddo and methods of use thereof
US8088824B2 (en)	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester
WO2009023845A2 (en)	2007-08-15	2009-02-19	The Board Of Regents Of The University Of Texas System	Combination therapy with synthetic triterpenoids and gemcitabine
WO2009058849A1 (en)	2007-10-29	2009-05-07	University Of Rochester	Use of electrophilic compounds for inducing platelet production or maintaining platelet function
AU2009203941B2 (en)	2008-01-11	2015-03-12	Reata Pharmaceuticals Holdings, LLC	Synthetic triterpenoids and methods of use in the treatment of disease
WO2009146216A2 (en) *	2008-04-18	2009-12-03	Reata Pharmaceuticals. Inc.	Antioxidant inflammation modulators: novel derivatives of oleanolic acid
PT2276493T (pt)	2008-04-18	2019-01-10	Reata Pharmaceuticals Inc	Moduladores de inflamação anti-oxidantes: derivados de ácidos oleonucleicos com uma modificação no grupo aminno e outras modificações em c-17
NZ588709A (en)	2008-04-18	2012-11-30	Reata Pharmaceuticals Inc	Antioxidant inflammation modulators: triterpenoid oleanolic acid derivatives with saturation in the c-ring
CN104250280A (zh)	2008-04-18	2014-12-31	里亚塔医药公司	抗氧化剂炎症调节剂:c-17同系化齐墩果酸衍生物
WO2009146218A2 (en)	2008-04-18	2009-12-03	Reata Pharmaceuticals, Inc.	Compounds including an anti-inflammatory pharmacore and methods of use
AU2009274037B2 (en)	2008-07-22	2015-07-09	Trustees Of Dartmouth College	Monocyclic cyanoenones and methods of use thereof
WO2010053817A1 (en)	2008-11-04	2010-05-14	Trustees Of Dartmouth College	Betulinic acid derivatives and methods of use thereof
US20120029071A1 (en)	2008-11-21	2012-02-02	The Johns Hopkins University	Compositions and methods for treating or preventing radiation injury
KR20140016441A (ko)	2009-02-13	2014-02-07	리아타 파마슈티컬즈, 아이엔씨.	무정형 ｃｄｄｏ-ｍｅ를 포함하는, 지연 방출형 경구 투여 조성물
EP2432476A4 (en)	2009-05-01	2013-03-20	Ophthotech Corp	METHOD FOR THE TREATMENT OR PREVENTION OF EYE DISEASES
SI2558105T1 (sl)	2010-04-12	2020-02-28	Reata Pharmaceuticals, Inc.	Bardoksolon metil za zdravljenje debelosti
WO2011140078A1 (en)	2010-05-04	2011-11-10	Concert Pharmaceuticals, Inc.	Synthetic triterpenoid derivatives
US20130288985A1 (en)	2010-07-15	2013-10-31	The Schepens Eye Research Institute Inc.	Compositions and methods of treatment of corneal endothelium disorders
CN102070697A (zh)	2010-12-09	2011-05-25	中国药科大学	一种齐墩果酸衍生物、其制备方法及用途
CN102079772A (zh)	2010-12-09	2011-06-01	中国药科大学	一类五环三萜-13,28-内酯化合物、其制备方法和用途
SG191181A1 (en)	2010-12-17	2013-07-31	Reata Pharmaceuticals Inc	Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
AU2012212509B2 (en)	2011-01-31	2016-01-21	ViiV Healthcare UK (No.4) Limited	C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
CN102093462B (zh)	2011-02-28	2012-11-21	贵州省中国科学院天然产物化学重点实验室	1α,2α-二羟基齐墩果酸的制备方法和应用
CN102153613B (zh)	2011-02-28	2013-08-14	贵州省中国科学院天然产物化学重点实验室	夏枯草酸的制备方法和应用
EA026847B1 (ru)	2011-03-11	2017-05-31	Рита Фармасьютикалз, Инк.	C4-монометилтритерпеноидные производные и способы их применения
WO2012154554A1 (en)	2011-05-06	2012-11-15	Catabasis Pharmaceuticals, Inc.	Fatty acid triterpene derivatives and their uses
CN102250189B (zh)	2011-05-20	2012-08-29	中国药科大学	一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物、其制备方法及医药用途
BR112014026640B1 (pt)	2012-04-27	2021-05-18	Reata Pharmaceuticals, Inc	compostos derivados de 2,2-difluoropropionamida de metil bardoxolona, formas polimórficas, composição farmacêutica, e uso dos mesmos
WO2013169740A2 (en)	2012-05-08	2013-11-14	Trustees Of Dartmouth College	Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
US8921419B2 (en)	2012-05-08	2014-12-30	Trustees Of Dartmouth College	Triterpenoids and compositions containing the same
US8981144B2 (en)	2012-05-08	2015-03-17	Trustees Of Dartmouth College	Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
US9556222B2 (en)	2012-06-15	2017-01-31	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
RU2487884C1 (ru)	2012-07-13	2013-07-20	Общество с ограниченной ответственностью "Дакор" (ООО "Дакор")	Средство, обладающее антиоксидантной, противовоспалительной, нейропротекторной, гиполипидемической, гипохолестеринемической, гипогликемической, гепатопротекторной, иммуносупрессорной активностями
CN103665087A (zh)	2012-09-03	2014-03-26	上海源力生物技术有限公司	一种萜类化合物及其在医药上的应用
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US20140073700A1 (en)	2012-09-10	2014-03-13	Abbvie Inc.	Glycyrrhetinic acid derivatives and methods of use thereof
US9278912B2 (en)	2012-09-10	2016-03-08	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
PL2892911T3 (pl)	2012-09-10	2018-03-30	Reata Pharmaceuticals, Inc.	Pochodne C17-heteroarylowe kwasu oleanolowego i sposoby ich zastosowania
CA2882418C (en)	2012-09-10	2021-05-04	Reata Pharmaceuticals, Inc.	C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
JP5972986B2 (ja)	2012-09-28	2016-08-17	アプライドファーマシューティカルサイエンスインコーポレイテッド	Ｃｄｄｏエチルエステルの多形体及びその用途
CN102887936A (zh)	2012-10-24	2013-01-23	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯晶型
CN102875634B (zh)	2012-10-24	2014-08-20	苏州晶云药物科技有限公司	2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
UY39092A (es)	2013-04-24	2021-03-26	Abbvie Inc	Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
MX2016002375A (es)	2013-08-23	2016-12-20	Reata Pharmaceuticals Inc	Métodos de tratamiento y prevencion de la disfunción endotelial utilizando metil bardoxololona o sus análogos.
EP3097089B1 (en)	2014-01-24	2021-02-24	Reata Pharmaceuticals, Inc.	Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
KR102686868B1 (ko)	2015-02-12	2024-07-19	리아타 파마슈티컬즈, 아이엔씨.	항산화 염증 조절제로서의 이미다졸릴 트리사이클릭 에논
KR20180061251A (ko)	2015-09-23	2018-06-07	리아타 파마슈티컬즈, 아이엔씨.	Il-17의 저해를 위한 c4-변형된 올레아놀산 유도체 및 다른 용도
AU2017356955B2 (en)	2016-11-08	2023-11-09	Reata Pharmaceuticals Holdings, LLC	Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof
TWI831738B (zh)	2016-12-16	2024-02-11	美商瑞塔醫藥有限責任公司	用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物

2013
- 2013-04-24 BR BR112014026640-9A patent/BR112014026640B1/pt active IP Right Grant
- 2013-04-24 TW TW106112410A patent/TWI623548B/zh active
- 2013-04-24 JP JP2015509119A patent/JP6410710B2/ja active Active
- 2013-04-24 PE PE2014001894A patent/PE20150160A1/es active IP Right Grant
- 2013-04-24 UA UAA201412683A patent/UA116209C2/uk unknown
- 2013-04-24 NZ NZ630222A patent/NZ630222A/en unknown
- 2013-04-24 MY MYPI2014003024A patent/MY172750A/en unknown
- 2013-04-24 UY UY0001034764A patent/UY34764A/es active IP Right Grant
- 2013-04-24 MX MX2014013076A patent/MX357060B/es active IP Right Grant
- 2013-04-24 PT PT171758857T patent/PT3444261T/pt unknown
- 2013-04-24 AU AU2013251602A patent/AU2013251602B2/en active Active
- 2013-04-24 EP EP17175885.7A patent/EP3444261B1/en active Active
- 2013-04-24 LT LTEP17175885.7T patent/LT3444261T/lt unknown
- 2013-04-24 CN CN201380034275.0A patent/CN104395332B/zh active Active
- 2013-04-24 RS RS20210286A patent/RS61544B1/sr unknown
- 2013-04-24 KR KR1020147032968A patent/KR102101774B1/ko active IP Right Grant
- 2013-04-24 EA EA201491972A patent/EA030468B1/ru unknown
- 2013-04-24 ME MEP-2017-178A patent/ME02926B/me unknown
- 2013-04-24 ES ES17175885T patent/ES2861393T3/es active Active
- 2013-04-24 AR ARP130101383A patent/AR092823A1/es not_active Application Discontinuation
- 2013-04-24 HU HUE13720708A patent/HUE035673T2/en unknown
- 2013-04-24 SI SI201331856T patent/SI3444261T1/sl unknown
- 2013-04-24 DK DK17175885.7T patent/DK3444261T3/da active
- 2013-04-24 US US13/869,833 patent/US8993640B2/en active Active
- 2013-04-24 EP EP13720708.0A patent/EP2841445B1/en active Active
- 2013-04-24 WO PCT/US2013/038064 patent/WO2013163344A1/en active Application Filing
- 2013-04-24 TW TW102114730A patent/TW201348245A/zh unknown
- 2013-04-24 CA CA2869783A patent/CA2869783C/en active Active
- 2013-04-24 LT LTEP13720708.0T patent/LT2841445T/lt unknown
- 2013-04-24 SG SG11201406868XA patent/SG11201406868XA/en unknown
- 2013-04-24 PL PL13720708T patent/PL2841445T3/pl unknown
- 2013-04-24 HU HUE17175885A patent/HUE053113T2/hu unknown
- 2013-04-24 RS RS20170770A patent/RS56154B1/sr unknown
- 2013-04-24 DK DK13720708.0T patent/DK2841445T3/en active
- 2013-04-24 PL PL17175885T patent/PL3444261T3/pl unknown
- 2013-04-24 ES ES13720708.0T patent/ES2634315T3/es active Active
- 2013-04-24 SI SI201330749T patent/SI2841445T1/sl unknown
- 2013-04-24 PT PT137207080T patent/PT2841445T/pt unknown
2014
- 2014-10-09 ZA ZA2014/07326A patent/ZA201407326B/en unknown
- 2014-10-21 DO DO2014000236A patent/DOP2014000236A/es unknown
- 2014-10-22 IL IL235275A patent/IL235275B/en active IP Right Grant
- 2014-10-24 CL CL2014002886A patent/CL2014002886A1/es unknown
- 2014-10-29 CO CO14240045A patent/CO7170182A2/es unknown
2015
- 2015-02-19 US US14/625,829 patent/US9701709B2/en active Active
- 2015-08-05 HK HK15107527.0A patent/HK1207086A1/xx unknown
- 2015-08-05 HK HK15107525.2A patent/HK1207085A1/xx unknown
2017
- 2017-06-14 US US15/622,568 patent/US11078230B2/en active Active
- 2017-08-22 HR HRP20171275TT patent/HRP20171275T1/hr unknown
- 2017-09-12 CY CY20171100959T patent/CY1119333T1/el unknown
2018
- 2018-09-25 JP JP2018178470A patent/JP6637136B2/ja active Active
2021
- 2021-03-26 CY CY20211100266T patent/CY1124130T1/el unknown
- 2021-06-25 US US17/304,778 patent/US12065464B2/en active Active
2024
- 2024-04-17 FR FR24C1015C patent/FR24C1015I1/fr active Active
- 2024-04-18 FI FIC20240012C patent/FIC20240012I1/fi unknown
- 2024-04-18 HU HUS2400010C patent/HUS2400010I1/hu unknown
- 2024-05-29 NL NL301276C patent/NL301276I2/nl unknown

Also Published As

Publication number	Publication date
PT2841445T (pt)	2017-09-01
NZ630222A (en)	2016-06-24
EP3444261B1 (en)	2021-01-13
EP3444261A1 (en)	2019-02-20
PE20150160A1 (es)	2015-02-19
EP2841445A1 (en)	2015-03-04
MX2014013076A (es)	2015-05-11
EP2841445B1 (en)	2017-06-14
PL3444261T3 (pl)	2021-07-19
ME02926B (me)	2018-04-20
CA2869783A1 (en)	2013-10-31
US20210355156A1 (en)	2021-11-18
AU2013251602A1 (en)	2014-10-23
KR20150003875A (ko)	2015-01-09
JP6410710B2 (ja)	2018-10-24
JP2015521166A (ja)	2015-07-27
BR112014026640B1 (pt)	2021-05-18
ES2861393T3 (es)	2021-10-06
US20150259377A1 (en)	2015-09-17
FIC20240012I1 (fi)	2024-04-18
WO2013163344A1 (en)	2013-10-31
SG11201406868XA (en)	2014-11-27
AR092823A1 (es)	2015-05-06
US9701709B2 (en)	2017-07-11
RS61544B1 (sr)	2021-04-29
RS56154B1 (sr)	2017-11-30
CA2869783C (en)	2022-06-21
KR102101774B1 (ko)	2020-04-20
LT2841445T (lt)	2017-09-11
PL2841445T3 (pl)	2017-10-31
US20130324599A1 (en)	2013-12-05
HK1207086A1 (en)	2016-01-22
US8993640B2 (en)	2015-03-31
CN104395332A (zh)	2015-03-04
HRP20171275T1 (hr)	2017-10-20
HK1207085A1 (en)	2016-01-22
CO7170182A2 (es)	2015-01-28
TW201348245A (zh)	2013-12-01
DOP2014000236A (es)	2015-04-30
PT3444261T (pt)	2021-03-12
US20180009839A1 (en)	2018-01-11
ZA201407326B (en)	2016-10-26
US11078230B2 (en)	2021-08-03
UA116209C2 (uk)	2018-02-26
JP2019011349A (ja)	2019-01-24
NL301276I2 (nl)	2024-06-24
CL2014002886A1 (es)	2015-02-06
AU2013251602B2 (en)	2017-09-28
HUE035673T2 (en)	2018-05-28
MY172750A (en)	2019-12-11
CY1119333T1 (el)	2018-02-14
EA030468B1 (ru)	2018-08-31
CN104395332B (zh)	2017-01-18
UY34764A (es)	2013-11-29
MX357060B (es)	2018-06-25
EA201491972A1 (ru)	2015-02-27
US12065464B2 (en)	2024-08-20
TW201726701A (zh)	2017-08-01
HUS2400010I1 (hu)	2024-05-28
DK3444261T3 (da)	2021-03-08
ES2634315T3 (es)	2017-09-27
DK2841445T3 (en)	2017-09-11
CY1124130T1 (el)	2022-05-27
LT3444261T (lt)	2021-05-10
SI3444261T1 (sl)	2021-04-30
HUE053113T2 (hu)	2021-06-28
TWI623548B (zh)	2018-05-11
JP6637136B2 (ja)	2020-01-29
SI2841445T1 (sl)	2017-12-29
BR112014026640A2 (pt)	2017-07-18
IL235275B (en)	2018-03-29

Publication	Publication Date	Title
FR24C1015I1 (fr)	2024-06-28	Derives 2,2-difluoropropionamide de bardoxolone methyle, leurs formes polymorphes et leurs procedes d'utilisation
FR22C1037I2 (fr)	2023-05-26	Procedes de glycoconjugaison et compositions
FR22C1047I1 (fr)	2022-10-14	Derives de benzimidazole-proline
FR17C1040I2 (fr)	2018-11-16	Derive antiviraux de 2,5-dibenzimidazol-5-yl-1-phenyl-pyrrolidine
HRP20181321T1 (hr)	2018-10-19	Derivati 2,2-difluoraopropionamida bardoksolon metila, polimorfni oblici i postupci njihove uporabe
SMT201600198B (it)	2016-08-31	Derivati di 1,2,4-triazina-4-ammina
FR22C1023I1 (fr)	2022-07-22	Forme polymorphe st-246 et procedes de preparation
BR302012003594S1 (pt)	2014-05-20	"configuração aplicada em fraco"
DK2922508T3 (da)	2021-06-14	Ostomipose i ét stykke
AR092198A1 (es)	2015-04-08	Derivados de pirazolopirimidinas
FR2962731B1 (fr)	2012-08-17	Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2973378B1 (fr)	2013-10-04	Derives d'acide hydroxybisphosphonique bifonctionnels
DE112013002488T8 (de)	2015-02-19	Vesikuläre Formulierungen, Kits und Verwendungen
BR112013010541A2 (pt)	2016-07-05	método de preparação de 1,3,5-trioxano
FR2985185B1 (fr)	2013-12-27	Utilisation en therapeutique de derives d'imidazopyridine
TH1401003816A (th)	2016-05-31	องค์ประกอบ, การสังเคราะห์, และ วิธีการของการใช้อนุพันธ์ฟีนิลไซโคลอัลคิลเมทธิลเอมีน
UA27795S (uk)	2014-09-25	Ковдра стьобана
ES1076370Y (es)	2013-01-31	"Figura didáctica"
FR2992645B1 (fr)	2014-08-01	Nouveaux derives de pyrrolidine
BR302012005687S1 (pt)	2014-11-11	" configuração aplicada em radiotelefone "
BR302012004864S1 (pt)	2014-05-27	"configuração aplicada em bolo"
BR302012006247S1 (pt)	2015-08-25	"configuração aplicada em instrumento cirúrgico"
BR302012005639S1 (pt)	2014-05-27	" configuração aplicada em sirene "
FR2988729B1 (fr)	2014-03-14	Compositions de 2,4,4,4-tetrafluorobut-1-ene et de 1-methoxyheptafluoropropane
TH1401006467A (th)	2016-09-28	อนุพันธ์ 2,2-ไดฟลูออโร โพรพิโอนาไมด์ของบาร์ดอกโซโลน เมทิล, รูปแบบที่เป็น โพลีมอร์ฟ และวิธีการใช้สารเหล่านั้น